www.fdanews.com/articles/131936-biomoda-picks-quintiles-for-early-stage-lung-cancer-detection-system
Biomoda Picks Quintiles for Early-Stage Lung Cancer Detection System
November 15, 2010
Cancer diagnostics company Biomoda, Inc. has allied with Quintiles Global Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath-stained cells to detect early stage lung cancer.
NewsBlaze
NewsBlaze